The aim of this study is to investigate the effects of thoracolumbar fascia mobilization and ultrasound-guided thoracolumbar interfascial 5% dextrose injection on pain, range of motion, disability, quality of life, proprioception, and fascial thickness and echogenicity in patients with nonspecific chronic low back pain.
-Primary Objective: The primary objective is to evaluate the effects of these interventions on pain, functional status and range of motion.
-Secondary Objective: The secondary objective is to assess the long-term effects on quality of life, proprioception, fascial thickness, and echogenicity.
Who can participate
Age range18 Years – 65 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion criteria
✓. Male or female patients aged 18 to 65 years
✓. Presence of low back pain lasting longer than 3 months
✓. No adequate response to medical treatment
✓. Voluntary participation in the study
Exclusion criteria
✕. Age below 18 or above 65 years
✕. Body mass index (BMI) greater than 30 kg/m²
✕. Pregnancy or breastfeeding
✕. Presence of coagulation disorders
✕. History of spinal surgery
✕. Presence of inflammatory or malignant diseases
✕. Local infection at the spine or injection site
✕
What they're measuring
1
Visual Analog Scale (VAS)
Timeframe: Baseline, after 1 month and 3 month changes
2
Lumbar spine range of motion (ROM)
Timeframe: Baseline, after 1 month and 3 month changes
3
Functional Status Assessment (Oswestry Disability Index - ODI)
Timeframe: Baseline, after 1 month and 3 month changes